Recent studies have shown high expression of transferrin receptor-1 (TfR1) in a variety of tumors including lung, breast, and bladder cancer as well as malignant glioma, but the clinical significance of TfR1 in tumor remains to be confirmed [12, 13]. The gene discussed is TFRC; the disease is malignant glioma.